MedTrace Logo

Effect of NT-proBNP Guided Treatment of Chronic Heart Failure

NCT00149422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether NT-proBNP guided treatment of chronic congestive heart failure will reduce heart failure related morbidity and mortality compared to therapy guided by standard clinical judgement.

Conditions

  • Heart Failure, Congestive

Interventions

DEVICE

NT-proBNP measurements

Sponsors & Collaborators

  • The Interuniversity Cardiology Institute of the Netherlands

    collaborator OTHER_GOV

  • Netherlands Heart Foundation

    lead OTHER

Principal Investigators

  • Dave JW van Kraaij, MD · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2009-01-31
Completion
2009-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149422 on ClinicalTrials.gov